OrthoPediatrics Corp. Files 8-K

Ticker: KIDS · Form: 8-K · Filed: Jan 14, 2025 · CIK: 1425450

Orthopediatrics Corp 8-K Filing Summary
FieldDetail
CompanyOrthopediatrics Corp (KIDS)
Form Type8-K
Filed DateJan 14, 2025
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.00025
Sentimentneutral

Sentiment: neutral

Topics: 8-K, disclosure, financials

Related Tickers: KIDS

TL;DR

OrthoPediatrics filed an 8-K on Jan 14, 2025. Check for updates.

AI Summary

OrthoPediatrics Corp. filed an 8-K on January 14, 2025, reporting a Regulation FD Disclosure and Financial Statements and Exhibits. The filing pertains to their operations as a company in the Surgical & Medical Instruments & Apparatus industry, with their principal executive offices located in Warsaw, Indiana.

Why It Matters

This 8-K filing indicates that OrthoPediatrics Corp. is providing updated information to the SEC, which could include material disclosures relevant to investors.

Risk Assessment

Risk Level: low — This is a routine filing of an 8-K, which typically contains standard disclosures and does not inherently signal significant risk.

Key Numbers

  • 001-38242 — SEC File Number (Identifies the company's filing history with the SEC.)
  • 26-1761833 — IRS Employer Identification Number (Company's tax identification number.)

Key Players & Entities

  • OrthoPediatrics Corp. (company) — Registrant
  • January 14, 2025 (date) — Date of Report
  • Warsaw, Indiana (location) — Principal executive offices
  • Nasdaq Global Market (exchange) — Exchange where Common Stock is registered

FAQ

What specific information is being disclosed in the Regulation FD Disclosure?

The filing does not specify the exact content of the Regulation FD Disclosure, only that it is being reported.

What are the key exhibits included with this 8-K filing?

The filing states 'Financial Statements and Exhibits' are included, but the specific exhibits are not detailed in this summary.

When was OrthoPediatrics Corp. incorporated?

The filing indicates the company is incorporated in Delaware.

What is the par value of OrthoPediatrics Corp.'s common stock?

The par value of the common stock is $0.00025 per share.

What is the SIC code for OrthoPediatrics Corp.?

The Standard Industrial Classification code is 3841, for Surgical & Medical Instruments & Apparatus.

Filing Stats: 505 words · 2 min read · ~2 pages · Grade level 10.4 · Accepted 2025-01-14 08:12:10

Key Financial Figures

  • $0.00025 — ange on which registered Common Stock, $0.00025 par value per share KIDS Nasdaq Global

Filing Documents

01. Regulation FD Disclosure

Item 7.01. Regulation FD Disclosure. The executive officers of OrthoPediatrics Corp. have several upcoming presentations to representatives of investors and analysts. The officers intend to use the material filed as Exhibit 99.1 herewith, in whole or in part, as part of those presentations. The information in this Item 7.01, including the information incorporated by reference herein from Exhibit 99.1, is furnished pursuant to Item 7.01 of Form 8-K and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 99.1 Orthopediatrics Corp. Investor Presentation dated January 2024 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). * * * * * * SIGNATURE Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. OrthoPediatrics Corp. Date: January 14, 2025 By: /s/ Daniel J. Gerritzen Daniel J. Gerritzen, General Counsel and Secretary - 2 -

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.